Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation.
about
Banking on iPSC--is it doable and is it worthwhileThe dichotomous functions of passenger leukocytes in solid-organ transplantationDonor hematopoietic progenitor cells in nonmyeloablated rat recipients of allogeneic bone marrow and liver grafts.Transplantation tolerance, microchimerism, and the two-way paradigm.Transplantation tolerance: the concept and its applicability.Chimerism after organ transplantationHematopoietic progenitor cell content of vertebral body marrow used for combined solid organ and bone marrow transplantation.Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation.Documentation in bone-marrow-augmented organ recipients of the presence of dendritic cell progenitors of donor originCombined simultaneous kidney/bone marrow transplantationEarly tolerance in pediatric liver allograft recipients.Microchimerism, dendritic cell progenitors and transplantation toleranceIdentification of donor-derived dendritic cell progenitors in bone marrow of spontaneously tolerant liver allograft recipients.Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival.Perioperative donor bone marrow infusion in recipients of organ allograftsHematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation.Murine liver allograft transplantation: tolerance and donor cell chimerismNew immunosuppressive drugs: mechanistic insights and potential therapeutic advancesMatching and the black recipientSpontaneous and iatrogenically augmented leukocyte chimerism in organ transplant recipientsProspects of clinical xenotransplantation.The current status of hepatic transplantation at the University of PittsburghThree years of follow-up of bone marrow-augmented organ transplant recipients: the impact on donor-specific immune modulationThe superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience.The two-way paradigm of transplantation immunology.Xenobiotics, chimerism and the induction of tolerance following organ transplantation.The lost chord: microchimerism and allograft survival.The influence of donor and recipient strains in isolated small bowel transplantation in rats.Frequent achievement of a drug-free state after orthotopic liver transplantation.The future of transplantation: with particular reference to chimerism and xenotransplantationThe role of HLA typing in clinical kidney transplants: 30 years later. The blind-folding of HLA matchingAugmentation of natural chimerism with donor bone marrow in orthotopic liver recipients.Multilineage hematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation. With oarticular reference to the liver.The bidirectional paradigm of transplant immunology.Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway ratsWeaning of immunosuppression in long-term liver transplant recipients.The biological basis of and strategies for clinical xenotransplantationAugmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cellsHepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience.Recent advances in hepatic transplantation at the University of Pittsburgh
P2860
Q28254023-044E143B-4C1C-4AFF-85AA-361B8D82F436Q28290158-A8269FA5-36F3-44E2-BF65-EB62FA6EBCCFQ30630433-13DEB0C9-E3D1-48F8-98F9-0F48B1A22D2DQ33534180-152D4DF7-46AA-4ABA-8A77-FFAF52BC4B58Q33732945-903C7E79-3103-4383-975F-B93B976DE7EFQ34201706-C51034A6-0E83-45FF-BE93-0988420DE2F8Q34219104-435B26B0-063E-4A07-B3CF-68E94F9C7E0EQ34232532-A04E60B3-2326-4418-A3F3-42C89E081728Q34232581-6929F2B9-DAD8-4305-BCAF-A7F59B7F6C96Q34232727-068197A3-9C23-4B55-9A19-0FDE566500C6Q34236936-1C8F2FBF-B280-480C-B480-C8A7240BC623Q34239907-DFEE34B4-379A-4E2B-8C71-8CE7A1B6011EQ34240562-35FFAF11-684A-4899-A3BA-9C6E28D28D7FQ34252156-739504CA-E277-4B01-B37C-524CCEB28C6EQ34256611-E0B00EA9-AC26-4CD1-A38B-1DEAE51EBA63Q34257352-0F696574-1BD6-4F49-BF3F-37AC055F1183Q34275121-68D56001-BEB7-4D0A-B20F-50F4DC921346Q34275358-40A57812-9028-47B1-A7B2-7A79423E9E6DQ34286412-F470EFE4-5E67-45B3-A991-5073B4DB58CBQ34289617-A60A5AE2-FC08-4547-B589-497BAF0549FAQ34291353-4EE7C8DD-EB35-4B53-B61B-C8D7430AAB9AQ34330449-3A797900-7737-4CFB-BD88-AB69EE731066Q34341198-CAB2FA7D-2A3D-4832-8773-5B7DAB09ED12Q34346715-EDB2D03D-EC20-4E31-A2ED-40153D74A4B4Q34346915-EB7ECCCE-8AF4-4BEE-8581-91B419CF8406Q34357964-AF7C768C-1698-4F7C-A9E0-2F67D748EF40Q34359678-00043EF9-DC83-42DC-BBEF-619569ADF52FQ34359692-CDC22DED-5A34-4C5F-8908-59222924C0F9Q34363655-121AFF89-A526-4788-9BDC-0CB3070D616FQ34363671-96A76D4B-ADB9-4FAF-81A5-A16D704DA056Q34369476-E28F906C-4E1A-4654-995A-D4DF55194CB0Q34383171-07E3D572-76A7-4C29-B6DF-E07CD22C6455Q34406804-E55AB910-ECC2-4E0D-9192-274DB97285D8Q34408645-DFD2AD8B-4F3C-462C-8747-E4C844260FEAQ34414935-52FA935D-CCC0-4D32-8181-59E85BFFE169Q34421356-800DB52E-116D-4C91-AC8B-3286E2C4C276Q34422862-9C0D610E-DC5A-4DAE-927C-1132797932DCQ34498150-6E8879ED-37DE-4E85-8F6C-E129A078E8E6Q34498238-13F1C07A-A6B7-48B9-9789-BD6C31836EC0Q34546018-E600A41C-D622-487B-9A64-F531ADA74AE5
P2860
Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation.
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Donor cell chimerism permitted ...... view of organ transplantation.
@ast
Donor cell chimerism permitted ...... view of organ transplantation.
@en
Donor cell chimerism permitted ...... view of organ transplantation.
@nl
type
label
Donor cell chimerism permitted ...... view of organ transplantation.
@ast
Donor cell chimerism permitted ...... view of organ transplantation.
@en
Donor cell chimerism permitted ...... view of organ transplantation.
@nl
prefLabel
Donor cell chimerism permitted ...... view of organ transplantation.
@ast
Donor cell chimerism permitted ...... view of organ transplantation.
@en
Donor cell chimerism permitted ...... view of organ transplantation.
@nl
P2093
P2860
P50
P1433
P1476
Donor cell chimerism permitted ...... view of organ transplantation.
@en
P2093
P2860
P304
P356
10.1016/0167-5699(93)90054-O
P577
1993-06-01T00:00:00Z